Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This observational clinical trial will investigate the following perioperative indices relating to cardiac surgery:
Over the past two decades, perioperative TOE has become routine part of monitoring in the setting of cardiac surgery. In many centres around the world nearly 100% of pateints undergoing cardiac surgery are monitored using this modality. There are several studies and observational reviews suggesting intraoperative TOE can change management and thus indirectly influence outcome in patients undergoing valve, aortic or bypass graft surgery. Certainly in our centre at The Heart Hospital, it is routine practce to perform an intraoperative TOE in all patients undergoing cardiac surgery in order to guide surgical and anaesthetic management of the patient. Despite this use of TOE there is very little evidence of how TOE influences patient related outcomes, both morbidity and mortality.
Several advances have occurred over the years involving both better technology to image the heart with TOE along with the development of novel measurements of heart function. As technology has evolved, many modalities and measurement have not been validated in the setting of cardiac surgery. In our observational clincal trial we aim to investigate the following:
While many of these measurements have been validated in the care of medical patients, they have not been examined in the surgical setting. In addition, its ability to predict outcome has never been tested. We believe this study will help us answer these important questions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cardiac surgery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cardiac Surgery and enoximone | Procedure | Does diastolic function change with cardiac surgery +/- enoximone |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in diastolic dysfunction -categorised as improved, stable or worse | Compare diastolic dysfunction before and after surgery in those that receive enoximone. Compare diastolic function before and after surgery in those that do not receive enoximone | Up to 12 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Systolic and diastolic data from the post operative transthoracic echocardiogram | Compare systolic and diastolic function on transthoracic echocardiography to intraoperative parameters | Up to 30 days |
| Duration of endotracheal intubation (in hours) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Any cardiac surgery
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Bonnie Kyle | Contact | 02034567898 | bonniekyle@doctors.net.uk |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006348 | Cardiac Surgical Procedures |
| D017335 | Enoximone |
| ID | Term |
|---|---|
| D013504 | Cardiovascular Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
| D019616 | Thoracic Surgical Procedures |
| D007093 | Imidazoles |
Not provided
Not provided
Not provided
Not provided
Not provided
How long patient remains intubated on ICU post operatively
| 0-30 days |
| Incidence of post operative atrial fibrillation | As above | 0-30 days |
| Duration of ICU stay | As above | 0-30 days |
| Duration of hospital stay | As above | 0-30 days |
| Cardiac Post Operatie Morbidity Score (C-POMS) | As above | 0-30 days |
| 30 day Major Adverse Cardiovascular Events | As above | 0-30 days |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |